L
Lexicon Pharmaceuticals, Inc.
LXRX · NASDAQ · Healthcare · 1.0B
Closing price
$1.68
-4.55% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
5.7×
Enterprise value / EBITDAEV/EBITDA
-15.4×
Free cash flow yieldFCF yield
-11.1%
Return on equityROE
-46.8%
Operating margin
-98.2%
Net debt / EBITDAbalance-sheet strength
-0.7×
Interest coverage
-5.9×
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.